In this regard, a study that measured the concentration of aCL IgG antibodies in the positive serum of COVID-19 before and after vaccination with different vaccines or following SARS-CoV-2 infection was not clinically pathogenic for the risk of thrombosis [63]. The gene discussed is ACLY; the disease is deep vein thrombosis.